Data / Form D filings / Nectero Medical Inc
Nectero Medical Inc: Form D filings
Nectero Medical Inc, a biotechnology company in Tempe, AZ, filed 3 Form D notices with the SEC between 2020 and 2024. The latest, on May 10, 2024, reports $32.8 million sold of a $96.6 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2343 W. University Drive, Suite D103, Tempe, AZ, 85281
- Phone
- (866) 755-4744
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1810951
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 10, 2024 | New notice | $96,636,154 | $32,791,551 | $63,844,603 | 30 | Apr 4, 2024 | sec.gov |
| Sep 1, 2021 | New notice | $18,189,496 | $18,189,496 | 31 | Aug 16, 2021 | sec.gov | |
| Apr 30, 2020 | New notice | $1,500,000 | $0 | $1,500,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anil Dasu | Director | |
| Colin Morrison | Director | |
| Bryan Ziegler | Executive Officer | |
| Bruce Roberts | Director | |
| Jack Springer | Executive Officer, Director | |
| Robert Whirley | Director |
Other biotechnology companies in Arizona that filed recently
- Gut-Brain-Axis Therapeutics Inc. $2 million · Oct 27, 2026
- Avery Therapeutics, Inc. $8.5 million · Sep 21, 2026
- CND Life Sciences, Inc. $6.3 million · Aug 3, 2026
Every Form D from the week of May 6, 2024 · All recent filings in Arizona · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Nectero Medical Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.